Skip to content

Use Sonography in Patients With Intrauterine Device Presenting With Bleeding

Intrauterine Contraceptive Device:Clinical and Sonographic Correlation in Patients Presenting With Bleeding

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03140800
Enrollment
60
Registered
2017-05-04
Start date
2017-06-30
Completion date
2019-03-31
Last updated
2017-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Brief summary

Intrauterine contraceptive device is one of the most efficient and reversible methods of birth control with low cost and long duration of use However, in the first year after insertion, between 5 and 15% of women will have their Intrauterine contraceptive device removed because of irregular uterine bleeding which have been attributed to the effect of contact between the device and the endometrium and even the pressure on the uterine muscle . The disharmonious relationship between the Intrauterine contraceptive device and the uterus is the cause of most of the bleeding complaints, so bleeding is related to improper position rather than the contraceptive method itself which should be excluded before abandoning the Intrauterine contraceptive device for any other method of birth control

Interventions

DEVICEintrauterine device

a method of contraception inserted in the uterus

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

patients using intrauterine contraceptive device complaining of bleeding

Exclusion criteria

* a-Associated uterine, cervical,or adenexal pathology b-Associated pelvic infection c-Generalized bleeding disorders d-Medications causing coagulation defects e-Medical disorders causing bleeding e.g hypertention f-Endocrine disorder as thyroid dysfunction g-Who refuse to share in the study

Design outcomes

Primary

MeasureTime frame
The intrauterine device-Endometrial distance3 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026